Terrapinn's world influenza congress Europe 2009. Part 1.
Terrapinn's World Influenza Congress Europe 2009, held in Brussels, included discussions of the current status of influenza worldwide. This conference report highlights selected presentations on the response to the H1N1 influenza pandemic, future strategies for combating pandemic influenza, and the role of novel vaccine technology in the pandemic response. Investigational vaccines discussed include M2del11HAavir H1N1 and M2del11HAavir H5N1 (FluGen Inc).
Veryard
Claire
C
Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK. claire.veryard@thomsonreuters.com
D000818:Animals; D004196:Disease Outbreaks / Q000517:prevention & control; D015195:Drug Design; D015507:Drugs, Investigational / Q000494:pharmacology; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology; D007252:Influenza Vaccines / Q000276:immunology*; D007251:Influenza, Human / Q000453:epidemiology / Q000517:prevention & control*; D013678:Technology, Pharmaceutical / Q000379:methods
D015507:Drugs, Investigational; D007252:Influenza Vaccines